Hairy Cell Leukemia (HCL)
(Leukemic Reticuloendotheliosis)En Español (Spanish Version)
Hairy cell leukemia (HCL) is a rare form of cancer involving white blood cells called B lymphocytes. White blood cells protect the body from infections and cancers. HCL gets its name from the tiny hair-like projections that protrude from the surface of HCL cancer cells. Illness results from the accumulation of these cancer cells in the bone marrow and spleen.
Cancer occurs when cells in the body (in this case white blood cells) divide without control or order. Normally, cells divide in a regulated manner. If cells keep dividing uncontrollably when new cells are not needed, a mass of tissue forms, called a growth or tumor. The term cancer refers to malignant tumors, which can invade nearby tissue and can spread to other parts of the body. A benign tumor usually does not invade or spread.
White Blood Cells
© 2008 Nucleus Medical Art, Inc.
A risk factor is something that increases your chance of getting a disease or condition. Specific risk factors for HCL are unknown. However, the disease tends to occur more often in men and in people over the age of 50.
HCL tends to develop slowly over a number of years. It often causes no symptoms at first. Eventually, the accumulation of cancer cells interferes with the normal function of the bone marrow, which often leads to a deficiency of red blood cells ( anemia ), white blood cells, and platelets.
Symptoms may include:
- Weakness and fatigue (due to anemia)
- Enlarged spleen
- Enlarged liver
- Recurrent infections, often with fevers (due to low white cell count)
- Ease in bruising and bleeding (due to low platelet count)
- Night sweats
- Swollen lymph nodes (rare)
The doctor will ask about your symptoms and medical history, and perform a physical exam. Tests may include:
HCL is a slow-growing cancer that does not require aggressive treatment early on. As HCL progresses, treatment may include:
If HCL causes the spleen to enlarge, the spleen may be surgically removed (called a splenectomy ).
This involves the use of drugs to kill cancer cells. The treatment may be given in many forms such as pill, injection, and via catheter. The drugs enter the bloodstream and travel through the body killing mostly cancer cells, but also some healthy cells. Several new drugs show promise in the treatment of hairy cell leukemia, and initial chemotherapy is becoming more common as new drugs are found that work well in managing the disease.
This involves the use of drugs like interleukin-2 and interferon to help boost the immune system to better fight and destroy cancer cells. It is also called biotherapy.
In this procedure, a patient's bone marrow is destroyed with high doses of chemotherapy and/or radiation. The bone marrow is then replaced with healthy bone marrow from another person (the donor) whose tissue closely matches the tissue of the patient.
Treatment of Symptoms
HCL patients with anemia often receive blood transfusions . Those with recurrent infections may receive antibiotics and/or other drugs to fight the infections.
American Cancer Society
The Leukemia & Lymphoma Society
National Cancer Institute
BC Cancer Agency
Canadian Cancer Society
The Leukemia & Lymphoma Society website. Available at: http://www.leukemia.org .
The Merck Manual of Medical Information . Simon and Schuster, Inc.; 2000.
National Cancer Institute website. Available at: http://www.cancernet.nci.nih.gov .
US National Library of Medicine website. Available at: http://www.nlm.nih.gov/ .
Last reviewed October 2007 by Igor Puzanov, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2011 EBSCO Publishing All rights reserved.